Wealthsource Partners, LLC Amgen Inc Transaction History

Wealthsource Partners, LLC

$1.52 Billion
Q4 2023

A detailed history of Wealthsource Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealthsource Partners, LLC holds 4,735 shares of AMGN stock, worth $1.25 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,735

Previous 8,319 43.08%

Holding current value

$1.25 Million

Previous $2.24 Million 39.02%

% of portfolio

0.09%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $916,428 - $1.03 Million	-3,584 Reduced 43.08%	4,735 $1.36 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $44,823 - $55,649	-205 Reduced 2.4%	8,319 $2.24 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $62,138 - $73,477	-290 Reduced 3.29%	8,524 $1.89 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $8,805 - $10,732	-39 Reduced 0.44%	8,814 $2.13 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $339,880 - $431,858	-1,484 Reduced 14.36%	8,853 $2.33 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $454,980 - $513,135	-2,027 Reduced 16.39%	10,337 $2.33 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $18,687 - $20,795	-81 Reduced 0.65%	12,364 $3.01 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $76,744 - $84,899	-350 Reduced 2.74%	12,445 $3.01 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $132,255 - $151,354	-665 Reduced 4.94%	12,795 $2.88 Million
Q3 2021 Nov 18, 2021	SELL	$212.27 - $248.7 $42,454 - $49,740	-200 Reduced 1.46%	13,460 $2.86 Million
Q2 2021 Nov 18, 2021	BUY	$233.58 - $259.14 $35,504 - $39,389	152 Added 1.13%	13,660 $3.33 Million
Q1 2021 Jun 21, 2021	SELL	$221.91 - $258.6 $221 - $258	-1 Reduced 0.01%	13,508 $3.36 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $406,578 - $484,161	-1,879 Reduced 12.21%	13,509 $3.11 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $52,561 - $58,452	-224 Reduced 1.43%	15,388 $3.91 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $526,174 - $645,688	-2,660 Reduced 14.56%	15,612 $3.68 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $296,140 - $392,762	-1,625 Reduced 8.17%	18,272 $3.7 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $408,504 - $525,068	-2,159 Reduced 9.79%	19,897 $4.8 Million
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $600,679 - $719,739	-3,450 Reduced 13.53%	22,056 $4.27 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $3.56 Million - $4.17 Million	21,351 Added 513.86%	25,506 $4.7 Million
Q1 2019 May 16, 2019	SELL	$180.87 - $203.88 $167,666 - $188,996	-927 Reduced 18.24%	4,155 $789,000
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $156,635 - $182,843	878 Added 20.88%	5,082 $989,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $34,093 - $38,435	184 Added 4.58%	4,204 $871,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $667,521 - $749,770	4,020 New	4,020 $742,000
Q4 2017 Feb 16, 2018	SELL	$168.79 - $188.59 $422,818 - $472,417	-2,505 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	2,505	2,505 $431,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.

Account

Wealthsource Partners, LLC Amgen Inc Transaction History